UTime Ltd WTO shares are trading higher by 12.5% to $1.62 Wednesday after the company announced a collaboration with Dr. Ehud Baron. The company says this is part of a strategy to advance its AI-driven health solutions and in expanding its smart medical wearable products.
The company says that Dr. Baron will work with UTime's team to create plans for a variety of health-related product lines.
UTime says the company’s focus will be on optimizing the existing blood pressure monitoring watch, but the company aims to broaden its offerings to include devices for detecting other key health indicators, such as heart rate and sleep.
How To Buy WTO Stock
By now you're likely curious about how to participate in the market for UTime – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of UTime, which is trading at $1.59 as of publishing time, $100 would buy you 62.89 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
According to data from Benzinga Pro, WTO has a 52-week high of $1.75 and a 52-week low of $0.13.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.